For liraglutide 3 mg (Saxenda) , NICE Technology Appraisal TA664 states treatment should be discontinued if patients do not lose at least 5% of their initial body weight after 12 weeks on the full 3 mg daily dose
NexLife may work with pharmacy partners that hold recognized quality, safety, and compliance credentials, which may include LegitScript certification, PCAB accreditation where applicable, state board licensure, FDA registration for 503B outsourcing facilities, and other pharmacy-specific credentials
Maintenance Dosing After Weight Goal Achievement Once you reach your target weight, this step-down approach helps maintain results while potentially reducing your overall medication dose
Should I contact my GP if I regain weight after stopping weight loss injections
Our goal is to help you achieve sustainable results that go beyond the scale, leading to a healthier overall lifestyle